Pharma and Biotech Patent Litigation Europe

Pharma and Biotech Patent Litigation Europe is a conference that examines international pharmaceutical and biotechnology patent disputes, cross-border litigation strategies, patent enforcement, exclusivity protection, and evolving European and global regulatory frameworks.

Key Topics

• Cross-border patent litigation and parallel proceedings across global jurisdictions
• Biosimilars litigation and exclusivity enforcement strategies
• Preliminary injunctions and recent case law developments
• Enforcement of method of manufacturing claims
• Coordination of opposition, litigation, and settlement strategies
• Innovator-innovator patent disputes involving blockbuster therapies and next-generation technologies
• Innovator-generic litigation involving treatment-related secondary patents
• EU and Hatch-Waxman developments in pharmaceutical patent litigation
• Bolar provisions and exclusivity reform under the EU Pharma Package and Biotech Act
• International patent enforcement trends and litigation challenges

Who should attend

• Patent litigators and intellectual property lawyers
• Pharmaceutical and biotechnology legal professionals
• In-house legal counsel
• Patent enforcement and litigation specialists
• Legal professionals representing innovator and generic pharmaceutical companies
• Biosimilar industry legal professionals
• Professionals involved in cross-border patent disputes and settlement strategies